Globus Medical (GMED) EBT (2011 - 2026)

Globus Medical (GMED) has reported EBT for 16 consecutive years, with $189.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT rose 0.87% year-over-year to $189.8 million; the trailing twelve-month figure through Jun 2026 stood at $660.1 million (up 76.72% YoY), and the FY2025 full-year result was $605.1 million, up 401.21% from the prior year.
• EBT improved to $189.8 million in Q2 2026 per GMED's latest filing, from $157.1 million in the prior quarter.
• Across five years, EBT topped out at $189.8 million in Q2 2026 and bottomed at -$8.6 million in Q1 2024.
• Historically, EBT has averaged $82.5 million across 5 years, with a median of $64.8 million in 2022.
• The widest YoY moves for EBT: up 2149.78% in 2024, down 113.61% in 2024.
• Over 5 years, EBT stood at $66.4 million in 2022, then tumbled by 62.33% to $25.0 million in 2023, then slipped by 1.31% to $24.7 million in 2024, then surged by 586.07% to $169.2 million in 2025, then climbed by 12.16% to $189.8 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $189.8 million, $157.1 million, and $169.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.